Ligand validation:5QDJ

JFP: N-(4-methyl-1,3-thiazol-2-yl)propanamide

JFP is a Ligand Of Interest in 5QDJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5QDJ_JFP_A_403	1%	13%	0.324	0.477	2.57	1.47	3	2	2	0	100%	0.24
5QDJ_JFP_A_401	0%	15%	0.667	0.603	2.27	1.52	3	1	2	0	100%	0.24
5QDJ_JFP_A_402	0%	24%	1.259	0.331	1.85	1.29	2	1	1	0	100%	0.24
7FRK_JFP_A_702	1%	5%	0.52	0.6	3.65	1.82	4	2	0	0	100%	0.38
9F5E_JFP_A_201	57%	63%	0.144	0.92	0.71	0.7	-	-	0	0	100%	0.66
5SNT_JFP_A_501	21%	49%	0.268	0.877	0.93	1.02	-	-	3	0	100%	0.98
5S3D_JFP_A_401	21%	58%	0.187	0.793	0.68	0.92	-	-	3	0	100%	0.66
7B7Y_JFP_A_513	11%	57%	0.195	0.708	0.76	0.88	-	-	0	0	100%	1
7HO7_JFP_B_202	2%	59%	0.389	0.631	0.81	0.76	-	-	0	0	100%	0.49

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.